GlaxoSmithKline PLC
30 March 2001
GlaxoSmithKline plc - Financial Calendar 2001
Set out below is the Company's financial calendar for 2001:
Date
Payment due for Glaxo Wellcome plc 2nd Interim Dividend 17 April 2001
(Glaxo Wellcome Ordinary Shares)
Payment date for SmithKline Beecham plc 4th Quarter 17 April 2001
Interim Dividend
(SmithKline Beecham Ordinary Shares & ADSs)
Announcement of 1st Quarter Results and 1st Quarter 24 April 2001
Interim Dividend
Payment date for Glaxo Wellcome plc 2nd Interim 27 April 2001
Dividend
(Glaxo Wellcome ADSs)
Ex dividend date 1st Quarter Interim Dividend 2 May 2001
Record date for 1st Quarter Interim Dividend 4 May 2001
Annual General Meeting 21 May 2001
Last day of election for the Dividend Reinvestment part 14 June 2001
of the GlaxoSmithKline Shareholder Investment Plan in
respect of the 1st Quarter Interim Dividend
Payment date of 1st Quarter Interim Dividend 5 July 2001
Announcement of 2nd Quarter Results and 2nd Quarter 24 July 2001
Interim Dividend
Ex dividend date 2nd Quarter Interim Dividend 1 August 2001
Record date for 2nd Quarter Interim Dividend 3 August 2001
Half Year Report published August 2001
Last day of election for the dividend reinvestment part 13 September 2001
of the GlaxoSmithKline Shareholder Investment Plan in
respect of the 2nd Quarter Interim Dividend
Payment date of 2nd Quarter Interim Dividend 4 October 2001
Announcement of 3rd Quarter Results and 3rd Quarter 23 October 2001
Interim Dividend
Ex dividend date 3rd Quarter Interim Dividend 31 October 2001
Record date for 3rd Quarter Interim Dividend 2 November 2001
Last day of election for the dividend reinvestment part 10 December 2001
of the GlaxoSmithKline Shareholder Investment Plan in
respect of 3rd Quarter Interim Dividend
Payment date of 3rd Quarter Interim Dividend 3 January 2002
Announcement of 2001 Full Year results 14 February 2002
Annual Report for 2001 published March 2002
S M Bicknell
Company Secretary
30 March 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.